INTRODUCTION
Connective tissue cells derived from diseased or normal synovial membrane can be propagated in a monolayer culture through 15 or more subcultures (1) . The cells generated from rheumatoid synovium differ in several ways from "normal" cells, and continue to exhibit these differences during their life in cell culture (2, 3) . This laboratory has demonstrated that rheumatoid cells are hypermetabolic, exhibit an unusually slow growth rate, and are relatively resistant to the suppressive effects of hydrocortisone on hyaluronic acid and collagen synthesis (2, 3) .
The studies of others have suggested that rheumatoid cells exhibit decreased synthesis or release of a component immunologically like cartilage protein-polysaccharide (4) . A recent study has cast doubt on the earlier finding that rheumatoid synovial fibroblasts, unlike normal fibroblasts, are resistant to infection with rubella virus (5) . The "abnormalities" which characterize rheumatoid cells may provide insight into alterations occurring within chronically inflamed rheumatoid joints.
Identification of these differences stimulated a search for their pathogenetic basis. Recent work from this laboratory demonstrated a polypeptide in lymphocytes and other mammalian cells capable of inducing hypermetabolic behavior in normal cells and augmenting the existing hypermetabolism in rheumatoid cells (6) (7) (8) (9) . As a result of these studies, it has been suggested that the connective tissue-activating peptide (CTAP)1 is a medi-'Abbreviations used in this paper: CPC, cetylpyridinium chloride; CTAP,connective tissue-activating peptide; KDO, 2-keto-3-deoxyoctonate.
ator in the inflammatory reaction, acting to regulate the transition from the exudative to the reparative phase (8) . More recently this laboratory demonstrated that rheumatoid synovial fibroblast strains have an activator polypeptide content approximately 4 times that of normal synovial cell strains, adding yet another abnormality to the list of altered characteristics of rheumatoid cells (9) . It was postulated that excess endogenous activator pep- tide may explain many of the known propagable abnormalities of these cells (9) .
No one, however, has discovered the inciting stimulus for these cellular alterations. Work attempting to demonstrate an infectious agent has failed to recover, in a reproducible way, infectious material from rheumatoid tissues. Recently, the focus of some investigators in this area has shifted toward the study of less typical microorganisms, such as slow viruses, as well as unusual bacteria, including diphtheroid organisms (10, 11) . In addition, attention has turned toward a study of situations in which initially infectious materials within tissue may be inflammatory but not recoverable in a form which can be propagated.
This paper provides data which show that extracts of common as well as unusual Gram-negative bacteria stimulate the energy metabolism of synovial cells in monolayer culture and cause them to produce large amounts of mucopolysaccharide, thus duplicating the major known actions of CTAP. Specifically, we show that the cell wall lipopolysaccharide, or "bacterial endotoxin," is responsible for much of the activity of the bacterial extracts.
METHODS
"Fibroblast cultures" were derived from synovial connective tissue obtained at amputations or arthrotomies. Explants from these sources were immobilized under cellophane, and after culture growth, the fibroblasts were dispersed with trypsin and transferred to larger flasks. Growing cells were nourished by semisynthetic medium containing 80% synthetic medium 1066, 10% fetal calf serum, and 10% pooled heatinactivated human serum, supplemented with L-glutamine. Penicillin (100 U/ml) and streptomycin sulfate (100 jug/ ml) were included in the culture medium. Sodium carbonate was used to adjust the pH to 7.4. Assay technique and biochemical measurements. Assay of test materials was carried out by the procedure used to measure CTAP (8) . 1 X 106 synovial fibroblasts were planted in replicate assay flasks with 2.0 ml serum-containing medium and allowed to adhere to the glass. Approximately 4 hr later, this medium was replaced with 2.0 ml of a nonserum-containing medium consisting of Eagle's synthetic medium supplemented with L-glutamine and containing HEPES ' buffer, penicillin, and streptomycin sulfate. Experimental samples, including whole bacterial extracts, purified endotoxins, or modifications thereof, were then introduced into these flasks and allowed to interact with the cells for a 2 or 3 day period. Hyaluronic acid, released into the culture medium, was measured and expressed as micrograms mucopolysaccharide per milligram sN-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid. cell protein per 24 hr. Glucose uptake from media and lactate formation were also measured in selected cases. Protein was measured by the method of Oyama and Eagle (12) . Mucopolysaccaride in the media was measured using a modified carbazole technique for uronic acids after isolation of the polymer (13) . The Barker-Summerson procedure was used for lactate measurement and the glucostat method for glucose (14, 15) . Cells used in assay were evaluated microscopically throughout the assay period.
Propagation of bacteria and preparation of extracts. Assorted known Gram- 150 ,ug of either enzyme was added to 1 ml of the whole bac-terial preparation or to 100 Ag of "purified" endotoxin.
Samples were incubated for 4 hr in phosphate buffer, 0.1 M, pH 7.0. Alkaline hydrolysis of endotoxin was conducted in 0.1 N NaOH at room temperature for varying periods of time.
Mucopolysaccharide isolation and characterization studies. The mucopolysaccharide formed by synovial fibroblasts in response to "activation" by a whole extract of E. coli was isolated and purified for subsequent characterization studies. 95% ethanol was added to pooled specimens of culture medium in a ratio of 4 parts ethanol to 1 part medium. The resulting precipitate was extracted with acetone, the dry residue dissolved in 0.05 M tris buffer, pH 7.8, and treated with pronase, 0.4 mg/ml, for 6 hr. A second pronase digestion was carried out using identical conditions, and then the sample was dialyzed against distilled water. ii ml of 5% cetylpyridinium chloride (CPC) in 02 M Na2SO4 was added to the dialyzed specimen to form a CPC-mucopolysaccharide complex. This CPC-mucopolysaccharide precipitate was washed with water and dissolved in absolute methanol; then 1.5 cc of 10% sodium acetate in methanol was added to form the sodium salt of the mucopolysaccharide. This precipitate was further purified in the following way: the sodium salt was dissolved in 0.2 M Na2SO4; CPC was then added to isolate the mucopolysaccharide which would precipitate at this ionic strength. The remaining solution was diluted 6-fold with distilled water in order to isolate the mucopolysaccharide precipitable with CPC in dilute solution. This precipitate was washed with distilled water, dissolved in methanol, and the sodium salt was reformed by adding sodium acetate in methanol.
Characterization studies on the isolated mucopolysaccharide fraction included uronic acid measurement by the method of Dische (20), and by an orcinol method (21) , to allow calculation of a carbazole: orcinol ratio. A sample was hydrolyzed with 4.0 N HCl at 1000C in a sealed glass tube for 20 hr and the hexosamine content measured (22) to allow calculation of the molar ratio of hexosamine: uronic acid in the hydrolyzed mucopolysaccharide. The hexosamine in the hydrolysate was identified by paper chromatography using authentic D-glucosamine and D-galactosamine as standards. Viscometry was carried out with several samples, using Ostwald viscometers with known buffer flow times. The relative viscosity, Pr, of a specimen is expressed as the ratio of its original efflux time to its efflux time after addition of 1.0 mg of testicular hyalunronidase in 0.05 ml of phosphate-buffered saline, pH 7 .0. The intrinsic viscosity, useful as an index of molecular weight, can be calculated from the relative viscosity, knowing the concentration of mucopolysaccharide in the specimen (23, 24) .
RESULTS
Effect of whole bacterial extracts on synovial fibroblasts. Addition of whole bacterial extracts to replicate fibroblast cultures caused marked increases in the mucopolysaccharide synthesis rate (Table I) extracts were those derived from Gram-negative bacteria. This suggested that the active component might be associated with the endotoxins which these organisms are known to contain.
Effect of purified endotoxin on fibroblast function. Representative results are shown in Table IV . Compared to the controls, there was marked stimulation of glucose uptake as well as lactate output by synovial fibroblasts in culture. The whole bacterial extracts were more active than the purified endotoxins in all parameters measured.
Effect of enzyme, heat, and base treatment on endotoxin bioactivity. Whole bacterial extracts and purified endotoxin were treated with proteolytic enzymes further to evaluate the active components (Table V) . Neither pronase nor trypsin had any measurable effect on the ability of the whole extract of a pathogenic E. coli to "activate" fibroblasts. Likewise, no inactivation resulted from treatment of a purified E. coli 0111: B4 endotoxin with either enzyme. On the other hand, heating whole bacterial preparations at 1000C for 10 min reduced the bioactivity of whole preparations. Activity reductions of 40% occurred consistently. Subsequent proteolytic enzyme treatment of this heat-treated endotoxin did not further reduce activity.
Table V also demonstrates that the "purified" E. coli endotoxin is less active than whole bacterial preparations. This endotoxin, obtained from Difco Laboratories, Detroit, Mich., had been prepared by a phenol-water The effect of alkaline hydrolysis on endotoxin activity was examined. Fig. 1 demonstrates a time-dependent reduction in the activity of the hydrolyzed endotoxin. 30% of the activity had disappeared after 6 min and complete loss of activity occurred in 3 hr. Other investigators have studied the effect of alkaline hydrolysis on the activity of endotoxin in other assay systems. Pyrogenicity is not completely eliminated by such treatment. Lethality for mice, although not decreased in the first 3 hr, is virtually eliminated at 6-8 hr (25) . Changes in mouse lethality associated with alkaline hydrolysis correlates with changes in molecular symmetry. Molecular dyssemmetry, postulated to include unfolding and swelling of the molecule, increases progressively between the 3rd and the 8th hr (25) . Changes associated with alkaline hydrolysis which have been shown to occur in other assay systems are in the same direction as the time-dependent changes demonstrated here in a cell culture system. Preparation and assay of the lipid moiety of endotoxin: "Lipid A." In 1933, Boivin et al. isolated a bacterial glycolipid (endotoxin) and investigated the effects of acid hydrolysis on the various activities of this preparation (17) . Their studies and subsequent studies by others showed that mild acid hydrolysis will split the endotoxin molecule, releasing a lipid moiety which retains biological activity in many systems. After hydrolysis, the remaining endotoxin fractions consist of degraded polysaccharide as well as unknown amounts of degraded lipid. The lipid moiety, or "Lipid A," although resembling the phospholipid portion of the endotoxin molecule as it occurs in the bacterial cell wall, is degraded to the extent that a significant amount of its total long-chain fatty acid content is removed (19) . In addition, lipid preparations may not be entirely free from intact cell wall lipopolysaccharide, since the hydrolytic methods investigated leave carbohydrate attached to the endotoxin molecule (19) .
Hydrolysis of S. typhosa 0901 endotoxin (Boivintype) resulted in evidence suggesting that the "lipid moiety" has a stimulatory effect on synovial fibroblasts. As shown in Table VI , the unhydrolyzed endotoxin produced a 3-fold rise in mucopolysaccharide synthesis over control values. The lipid fraction was not diminished in biological activity, whereas the polysaccharide portion failed to show activity above the controls.
In view of our inability to evaluate the possibility that the activity of "Lipid A" was due to contaminating undegraded endotoxin, we studied, through the courtesy of Dr. Edward C. Heath of Pittsburgh, cell wall extracts of mutant E. coli. E. coli J-5, an epimerase-free mutant, lacks galactose and all sugars distal to galactose. Therefore, it consists of "Lipid A," 2-keto-3-deoxyoctonate (KDO), and a considerably shortened polysaccharide core (26) . E. coli RC-59 contains only "Lipid A" and KDO as constituents of its cell wall glycolipid. No poly8Heath, E. C. 1971. Personal communication.
saccharide core is present. Table VII shows the results of assay of the products of the mutant E. coli. Endotoxins from both the J-5 and RC-59 mutants retain the ability to activate synovial fibroblasts.
Endotoxin-synovial fibroblast interaction. Endotoxinsynovial fibroblast interaction experiments attempted to investigate endotoxin uptake by cells and to assess the effect of uptake, on the endotoxin molecule. A normal synovial fibroblast cell line was treated with 30 Isg/ml E. coli 01 11: B4 endotoxin for 70 hr. The control for this experiment consisted of the same normal synovial cell line supported by nutrient medium for 70 hr without endotoxin. During the treatment period, both the control and endotoxin-treated cells were maintained in nonserum-containing medium. Both the control and treated cells were washed thoroughly with buffered saline, and cell extracts were prepared by a repeated freeze-thaw technique. Centrifuged extracts were then assayed for their ability to induce increases in mucopolysaccharide synthesis by fibroblasts, as in previous experiments. Table VIII shows that the saline extracts of the endotoxin-treated cells resulted in a 3.6-fold increase in mucopolysaccharide synthesis rate, whereas extracts of the controls produced a 2.6-fold rise. Treatment of the extracts with heat resulted in elimination of activity in the controls, but left residual activity in the extracts of the endotoxin-treated fibroblasts. Activity of the control cells was therefore presumed to be due entirely to heatlabile endogenous activator polypeptide (8) , whereas the treated extracts must have contained another active principle.
A portion of the treated cell extracts was fractionated on Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), and activity was demonstrated in the void volume eluate, suggesting a molecular weight of more than 150,000 for the active material.
Thus, extracts of the treated cells contained heat-stable activity with a molecular weight in the range of that Characterization of the mucopolysaccharide. 96% of the mucopolysaccharide recovered from the medium samples was precipitated with cetylpyridinium chloride from dilute solution rather than from 0.2 M Na2SO4. This suggested that the polymer formed by fibroblasts in response to stimulation by bacterial products was a nonsulfated one such as hyaluronic acid (27) . The purified fraction was then subjected to further characterization studies. The Dische carbazole: orcinol ratio was 1.35, indicating that the uronic acid was largely glucuronic acid, and the molar ratio of hexosamine to uronic acid was 1.16: 1. Chromatography of the purified sample showed that all of the hexosamine moved with D-glucosamine. No galactosamine was seen. The intrinsic viscosity [n] of the analyzed mucopolysaccharide ranged from 29.6 to 54.0 dl/g, values characteristic of synovial fluid hyaluronate. These findings suggest that hyaluronic acid is the predominant mucopolysaccharide made by normal synovial fibroblasts in response to "activation" by a whole extract of E. coli D-10.
DISCUSSION
These studies show that Gram-negative bacterial products have a marked effect on the behavior of synovial fibroblasts in monolayer culture. They stimulate these cells to produce large amounts of hyaluronic acid and to increase glucose uptake and lactate production. Spe The way in which bacterial extracts participate in inducing these changes is not clear. The abnormalities produced, collectively referred to as "activation phenomena," duplicate the major known actions of connective tissue-activating peptide (CTAP). CTAP, postulated to be a mediator in the inflammatory reaction, is thought of as a regulator in the progression of inflammation from the acute to the chronic phase (8) . In illnesses characterized by chronic synovitis, persistent high levels of activator materials might "freeze" inflammatory activity in the "reparative" phase. Materials from bacteria might participate with CTAP in producing hypermetabolic behavior by synovial fibroblasts, possibly by inducing formation of new CTAP, or by activating peptide present in inactive form. An alternative possibility is that bacterial extracts act independently of CTAP. Experiments designed to test the various possibilities are in progress.
These in vitro experiments are of interest in view of others' in vivo studies which show that Gram-negative bacterial endotoxin will produce synovial inflammation. Hollingsworth and Atkins reported that endotoxin injected into the rabbit knee joint induced a sustained inflammatory response (30) . Their studies showed that the rabbit synovium was sensitive to very small quantities (5 X 10' g) of endotoxin placed intraarticularly. Animals that were made "tolerant" to endotoxin had an undiminished inflammatory response after intra-articular injection (30) . Furthermore, Aoki and Ikuta reported the experimental production of arthritis in rabbits during lethal S. typhosa 0-901 endotoxemia. Intravenous injection of 0.1 mg/kg caused marked synovial inflammation. The authors were able to demonstrate endotoxin within synovial lining cells of the treated rabbits by immunohistochemical techniques. Their studies demonstrated a decline in serum complement; this suggested to them that an immune mechanism might be partially responsible for the lesion (31) .
In addition to the possible importance of endotoxin and other noninfectious bacterial extracts in producing rheumatoid inflammation, these materials might be instrumental in producing and sustaining inflammation in pyogenic arthritis, particularly in joints infected with Gram-negative bacteria. Braude, Jones, and Douglas demonstrated the persistence of endotoxin in rabbit synovial tissue long after an initial E. coli pyogenic arthritis had become sterile. Although the joints were s'erile 2 wk after the onset of infection, joint swelling continued, and purulent exudate persisted up to 8 wk. E. coli somatic antigen could be recovered from the rabbit joints 2 wk after they had become sterile. The recovered endotoxin was shown to have retained certain of its toxic properties; that is, it produced a pyogenic response and a hemagglutinin antibody rise in recipient rabbits. The authors also showed that the intra-articular injection of purified endotoxin produced local inflammatory changes comparable to that caused by living organisms (32) .
The concept of bacterial products as a cause for synovial inflammation is interesting with regard to other diseases in which bacteria are difficult to recover from joint fluid, such as gonococcal arthritis in the early migratory phase, as well as arthritis associated with subacute bacterial endocarditis. In ulcerative colitis and regional enteritis, chronic inflammatory diseases of the intestinal wall, bacterial products may play a role in the synovitis which sometimes occurs.
The present studies show that bacterial products exert multiple effects on isolated synovial cells. The data presented may contribute to understanding the mechanism of experimental endotoxin-induced arthritis in animals. In addition, these findings support the idea that endotoxin might be important in human diseases characterized by chronic synovitis. In this connection, the similarity of changes induced in normal cells by endotoxin to those which characterize rheumatoid cells is particularly interesting. It is possible that the persistence of endotoxin in articular tissues in undetoxified form might account for continued local inflammatory changes.
